Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy

ISSN： 1473-0804

Source： Climacteric, Vol.16, Iss.1, 2013-08, pp. : 37-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy

By Jaisamrarn U.

Climacteric, Vol. 16, Iss. 3, 2013-06 ,pp. : 347-355

Informa Healthcare

Access to resources Recommend Favorite

The role of local vaginal estrogen treatment in urogenital atrophy

By Ulrich Lian

Expert Review of Obstretrics and Gynecology, Vol. 7, Iss. 6, 2012-11 ,pp. : 545-556

Informa Healthcare

Access to resources Recommend Favorite

Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview

By Al-Baghdadi O. Ewies A. A. A.

Climacteric, Vol. 12, Iss. 2, 2009-04 ,pp. : 91-105

Informa Healthcare

Access to resources Recommend Favorite

Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review

By Sarkar N. N.

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 4, 2003-12 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy

By Barentsen R. van de Weijer P.H.M. Schram J.H.N.

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 1, 1997-01 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite